» Articles » PMID: 39282019

Sensors and Devices Guided by Artificial Intelligence for Personalized Pain Medicine

Overview
Date 2024 Sep 16
PMID 39282019
Authors
Affiliations
Soon will be listed here.
Abstract

Personalized pain medicine aims to tailor pain treatment strategies for the specific needs and characteristics of an individual patient, holding the potential for improving treatment outcomes, reducing side effects, and enhancing patient satisfaction. Despite existing pain markers and treatments, challenges remain in understanding, detecting, and treating complex pain conditions. Here, we review recent engineering efforts in developing various sensors and devices for addressing challenges in the personalized treatment of pain. We summarize the basics of pain pathology and introduce various sensors and devices for pain monitoring, assessment, and relief. We also discuss advancements taking advantage of rapidly developing medical artificial intelligence (AI), such as AI-based analgesia devices, wearable sensors, and healthcare systems. We believe that these innovative technologies may lead to more precise and responsive personalized medicine, greatly improved patient quality of life, increased efficiency of medical systems, and reducing the incidence of addiction and substance use disorders.

Citing Articles

Trends and Hotspots in Nanomedicine Applications for Pain: A Bibliometric Analysis from 1999 to 2024.

Wang S, He Y, Huang Y ACS Omega. 2025; 10(6):6147-6163.

PMID: 39989766 PMC: 11840773. DOI: 10.1021/acsomega.4c10893.


Smart Contact Lenses: Disease Monitoring and Treatment.

Pan M, Zhang Z, Shang L Research (Wash D C). 2025; 8:0611.

PMID: 39931295 PMC: 11808174. DOI: 10.34133/research.0611.


Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review.

Hulimane Shivaswamy R, Binulal P, Benoy A, Lakshmiramanan K, Bhaskar N, Pandya H ACS Mater Au. 2025; 5(1):115-140.

PMID: 39802146 PMC: 11718548. DOI: 10.1021/acsmaterialsau.4c00125.


Advances in Biointegrated Wearable and Implantable Optoelectronic Devices for Cardiac Healthcare.

Li C, Bian Y, Zhao Z, Liu Y, Guo Y Cyborg Bionic Syst. 2024; 5:0172.

PMID: 39431246 PMC: 11486891. DOI: 10.34133/cbsystems.0172.

References
1.
Tustumi F, Andreollo N, Aguilar-Nascimento J . FUTURE OF THE LANGUAGE MODELS IN HEALTHCARE: THE ROLE OF CHATGPT. Arq Bras Cir Dig. 2023; 36:e1727. PMC: 10168663. DOI: 10.1590/0102-672020230002e1727. View

2.
Ruffini G, Wendling F, Merlet I, Molaee-Ardekani B, Mekonnen A, Salvador R . Transcranial current brain stimulation (tCS): models and technologies. IEEE Trans Neural Syst Rehabil Eng. 2012; 21(3):333-45. DOI: 10.1109/TNSRE.2012.2200046. View

3.
Aminizadeh S, Heidari A, Dehghan M, Toumaj S, Rezaei M, Jafari Navimipour N . Opportunities and challenges of artificial intelligence and distributed systems to improve the quality of healthcare service. Artif Intell Med. 2024; 149:102779. DOI: 10.1016/j.artmed.2024.102779. View

4.
Korsch B, GOZZI E, Francis V . Gaps in doctor-patient communication. 1. Doctor-patient interaction and patient satisfaction. Pediatrics. 1968; 42(5):855-71. View

5.
Torous J, Bucci S, Bell I, Kessing L, Faurholt-Jepsen M, Whelan P . The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry. 2021; 20(3):318-335. PMC: 8429349. DOI: 10.1002/wps.20883. View